TickerFactsScreenerDevelopers

UroGen Pharma Ltd. (URGN) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2014: $3.87M2015: $17.98M2016: $21.36M2017: $37.00M2018: $101.32M2019: $49.69M2020: $52.86M2021: $44.36M2022: $55.41M2023: $95.00M2024: $171.99M2025: $110.75M$110.75M
2014Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$110.75M-35.6%
2024$171.99M+81.0%
2023$95.00M+71.5%
2022$55.41M+24.9%
2021$44.36M-16.1%
2020$52.86M+6.4%
2019$49.69M-51.0%
2018$101.32M+173.8%
2017$37.00M+73.2%
2016$21.36M+18.8%
2015$17.98M+364.5%
2014$3.87M—